S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
How will EU ban and West's price cap on Russian diesel work?
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Evacuations urged in Ohio town as train wreck smolders
Is C3.ai Artificial Intelligence Product Suite a Gamechanger?
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
How will EU ban and West's price cap on Russian diesel work?
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Evacuations urged in Ohio town as train wreck smolders
Is C3.ai Artificial Intelligence Product Suite a Gamechanger?
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
How will EU ban and West's price cap on Russian diesel work?
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Evacuations urged in Ohio town as train wreck smolders
Is C3.ai Artificial Intelligence Product Suite a Gamechanger?
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
How will EU ban and West's price cap on Russian diesel work?
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Evacuations urged in Ohio town as train wreck smolders
Is C3.ai Artificial Intelligence Product Suite a Gamechanger?
OTCMKTS:ORINY

Orion Oyj - ORINY Stock Forecast, Price & News

$26.26
-1.79 (-6.38%)
(As of 01/19/2023)
Add
Compare
Today's Range
$26.26
$26.26
50-Day Range
$20.11
$28.05
52-Week Range
$20.11
$28.05
Volume
100 shs
Average Volume
6 shs
Market Capitalization
$7.41 billion
P/E Ratio
32.83
Dividend Yield
1.86%
Price Target
N/A
ORINY stock logo

About Orion Oyj (OTCMKTS:ORINY) Stock

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, other European countries, North America, and internationally. It provides prescription drugs and self-care products, including Nubeqa for the treatment of prostate cancer; dexdor and Precedex for intensive care sedative; Stalevo and Comtess/Comtan for Parkinson's disease; Simdax for acute decompensated heart failure; and Fareston for breast cancer, as well as Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler drugs for the treatment of asthma and chronic obstructive pulmonary disease. The company also offers veterinary drugs comprising Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo, and Tessie; and APIs for generic and proprietary drugs, as well as provides contract manufacturing services. In addition, it markets and sells veterinary drugs manufactured by other international companies. The company serves various healthcare service providers and professionals, such as specialist and general practitioners, veterinarians, pharmacies, hospitals, healthcare centers, clinics, and laboratories, as well as consumers with pets. Orion Oyj has partnership with Propeller Health to connect the Easyhaler(R) product portfolio for the treatment of asthma and COPD; and a research collaboration and license agreement with Alligator Bioscience AB (publ) to discover and develop new bispecific antibody cancer therapeutics. Orion Oyj was founded in 1917 and is headquartered in Espoo, Finland.

Receive ORINY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Orion Oyj and its competitors with MarketBeat's FREE daily newsletter.

ORINY Stock News Headlines

Cash Holders STILL Aren't Taking Steps to Prepare
Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.
40,443 Orion Corporation A shares converted into B shares
Orion Corporation: Acquisition of Own Shares 04.11.2022
Cash Holders STILL Aren't Taking Steps to Prepare
Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.
Orion Corporation completed share acquisitions
Orion Corporation: Acquisition of Own Shares 03.11.2022
Orion Corporation: Acquisition of Own Shares 02.11.2022
Orion Corporation: Acquisition of Own Shares 01.11.2022
Orion Corporation: Acquisition of Own Shares 31.10.2022
Orion Corporation: Acquisition of Own Shares 28.10.2022
Orion Corporation: Acquisition of Own Shares 27.10.2022
ORION CORPORATION: ACQUISITION OF OWN SHARES 26.10.2022
83,587 Orion Corporation A shares converted into B shares
Orion Corporation: Acquisition of Own Shares 25.10.2022
Orion Corporation: Acquisition of Own Shares 24.10.2022
Orion Corporation: Acquisition of Own Shares 21.10.2022
Orion Group Interim Report 1–9/2022
Orion Corporation: Acquisition of Own Shares 19.09.2022
See More Headlines
Receive ORINY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Orion Oyj and its competitors with MarketBeat's FREE daily newsletter.

ORINY Company Calendar

Today
2/06/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Private households
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:ORINY
Previous Symbol
NASDAQ:ORINY
CIK
N/A
Fax
N/A
Employees
3,355
Year Founded
N/A

Profitability

Net Income
$229.29 million
Pretax Margin
23.30%

Debt

Sales & Book Value

Annual Sales
$1.23 billion
Cash Flow
$1.00 per share
Book Value
$3.13 per share

Miscellaneous

Free Float
N/A
Market Cap
$7.41 billion
Optionable
Not Optionable
Beta
0.41

Key Executives

  • Mr. Timo Lappalainen (Age 61)
    Advisor
    Comp: $1.85M
  • Dr. Liisa Hurme (Age 56)
    Pres, CEO & Chairman of Exec. Management Board
  • Mr. Jari Karlson M.Sc. (Age 62)
    M.Sc. (Econ.), CFO, Sr. VP of Animal Health & Member of the Exec. Management Board
  • Mr. Olli Huotari Ll.M. (Age 57)
    Sr. VP of Corp. Functions, Gen. Counsel, Sec. & Member of Exec. Management Board
  • Ms. Satu Ahomäki M.Sc. (Age 57)
    M.Sc. (Econ.), Sr. VP of Commercial Operations & Member of the Exe. Mgmt. Board
  • Ms. Virve Laitinen M.Sc. (Tech.) (Age 51)
    MBA, Sr. VP of Specialty Products & Member of Exec. Management Board
  • Prof. Outi Vaarala M.D. (Age 61)
    Ph.D., Sr. VP for R&D and Member of Exec. Management Board
  • Mr. Juhani Kankaanpaa
    Sr. VP of Global Operations & Member of Exec. Management Board
  • Mr. Tuukka Hirvonen M.Sc.(Soc.)
    Investor Relations & Financial Communications Officer
  • Ms. Terhi Ormio
    VP of Communications













ORINY Stock - Frequently Asked Questions

Should I buy or sell Orion Oyj stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Orion Oyj in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" ORINY shares.
View ORINY analyst ratings
or view top-rated stocks.

How have ORINY shares performed in 2023?

Orion Oyj's stock was trading at $28.05 on January 1st, 2023. Since then, ORINY stock has decreased by 6.4% and is now trading at $26.26.
View the best growth stocks for 2023 here
.

How often does Orion Oyj pay dividends? What is the dividend yield for Orion Oyj?

Orion Oyj declared a dividend on Saturday, March 19th. Investors of record on Friday, March 25th will be paid a dividend of $0.5036 per share on Monday, April 18th. This represents a yield of 2.6%. The ex-dividend date is Thursday, March 24th.
Read our dividend analysis for ORINY
.

Is Orion Oyj a good dividend stock?

Orion Oyj (OTCMKTS:ORINY) pays an annual dividend of $0.49 per share and currently has a dividend yield of 1.86%. The dividend payout ratio is 61.25%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for ORINY.

What is Orion Oyj's stock symbol?

Orion Oyj trades on the OTCMKTS under the ticker symbol "ORINY."

How do I buy shares of Orion Oyj?

Shares of ORINY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Orion Oyj's stock price today?

One share of ORINY stock can currently be purchased for approximately $26.26.

How much money does Orion Oyj make?

Orion Oyj (OTCMKTS:ORINY) has a market capitalization of $7.41 billion and generates $1.23 billion in revenue each year. The company earns $229.29 million in net income (profit) each year or $0.80 on an earnings per share basis.

How many employees does Orion Oyj have?

The company employs 3,355 workers across the globe.

How can I contact Orion Oyj?

Orion Oyj's mailing address is Orionintie 1A, Espoo H9, 02200. The official website for the company is www.orion.fi. The company can be reached via phone at 358 10 4261 or via email at firstname.lastname@orion.fi.

This page (OTCMKTS:ORINY) was last updated on 2/6/2023 by MarketBeat.com Staff